This topic contains a solution. Click here to go to the answer

Author Question: Describe genotyping. What will be an ideal response?[br][br][b][color=#347235]Question ... (Read 74 times)

HudsonKB16

  • Hero Member
  • *****
  • Posts: 535
Describe genotyping.
 
  What will be an ideal response?

Question 2

Explain why some drugs are classified as DMARDs. What is the difference between a DMARD and an NSAID?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

JYan

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

Genotyping classifies an organism according to changes found at the level of the DNA.

Answer to Question 2

Drugs that can actually change the course of a disease, making the disease less severe or progress more slowly, are called disease-modifying. DMARDs slow the progression of rheumatoid arthritis. An NSAID does not change the underlying mechanism of rheumatoid arthritis or change the course of the disease; NSAIDs only relieve some of the symptomatology.




HudsonKB16

  • Member
  • Posts: 535
Reply 2 on: Jun 27, 2018
Thanks for the timely response, appreciate it


amynguyen1221

  • Member
  • Posts: 355
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The largest baby ever born weighed more than 23 pounds but died just 11 hours after his birth in 1879. The largest surviving baby was born in October 2009 in Sumatra, Indonesia, and weighed an astounding 19.2 pounds at birth.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

For a complete list of videos, visit our video library